Skip to main content
JANX logo

JANX · Janux Therapeutics, Inc.

Track JANX — free
$18.03 -0.75 (-3.99%) At close · Aug 28
Market Cap
$1.10B
Shares
61.14M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-06-02 Janeen Noel Doyle 4,059
2026-04-13 ANDY MEYER 1,877
2026-04-02 ZACHARIAH A MCIVER 74,802
2026-01-26 ANDY MEYER 178,767
2026-01-23 ANDY MEYER 118,122
2025-12-15 BYRON C ROBINSON 16,666
2025-12-08 BYRON C ROBINSON 50,000
2025-12-02 BYRON C ROBINSON 63,125
2025-12-01 ANDREW MEYER 3,333
2025-11-14 ANDREW MEYER 3,333
2025-10-28 ANDREW MEYER 16,665
2025-05-01 ANDREW MEYER 3,333
2025-04-21 ANDREW MEYER 3,334
2025-03-03 ANDREW MEYER 3,334
2025-02-03 ANDREW MEYER 3,334
2025-01-07 Campbell David Alan 5,000
2025-01-02 ANDREW MEYER 13,334
2024-12-26 Campbell David Alan 25,000
2024-11-01 Avalon Ventures XI, L.P. 56,440
2024-11-01 Reardon Tighe 2,999
2024-11-01 Lichter Jay 1,139
2024-11-01 Avalon BioVentures I, LP 10,934
2024-11-01 Reardon Tighe 5,202
2024-11-01 Avalon BioVentures SPV I, L.P. 57,627
2024-10-28 Reardon Tighe 15,122
2024-10-28 Reardon Tighe 9,061
2024-10-28 Lichter Jay 3,419
2024-10-25 Avalon BioVentures I, LP 32,800
2024-10-25 Avalon BioVentures SPV I, L.P. 172,880
2024-10-25 Avalon Ventures XI, L.P. 169,320
2024-10-24 Reardon Tighe 217,690
2024-10-24 Lichter Jay 4,921
2024-10-23 Avalon BioVentures SPV I, L.P. 248,797
2024-10-23 Avalon Ventures XI, L.P. 243,672
2024-10-23 Reardon Tighe 13,039
2024-10-23 Avalon BioVentures I, LP 47,203
2024-10-21 Reardon Tighe 6,324
2024-10-21 Reardon Tighe 10,769
2024-10-21 Lichter Jay 2,434
2024-10-18 Avalon BioVentures SPV I, L.P. 120,680
2024-10-18 Avalon Ventures XI, L.P. 118,194
2024-10-18 Avalon BioVentures I, LP 22,895
2024-10-17 Lichter Jay 1,842
2024-10-17 Reardon Tighe 4,784
2024-10-17 Reardon Tighe 8,158
2024-10-16 Avalon Ventures XI, L.P. 89,653
2024-10-16 Lichter Jay 10,957
2024-10-16 Reardon Tighe 28,993
2024-10-16 Avalon BioVentures I, LP 17,367
2024-10-16 Avalon BioVentures SPV I, L.P. 91,539
Showing 1–50 of 87 filings
Key facts CIK 1817713 CUSIP 47103J105 13F (30d) 173 filings 172 filers Visit website